MacroGenics
MGNX
#9393
Rank
โ‚น7.78 B
Marketcap
โ‚น123.08
Share price
-0.72%
Change (1 day)
-57.13%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.49. In 2024 the company made an earnings per share (EPS) of -โ‚น96.12 a decrease over its 2023 EPS that were of -โ‚น13.48.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.82%
2024-โ‚น96.12613.33%
2023-โ‚น13.48-92.31%
2022-โ‚น175.18-42.14%
2021-โ‚น302.7536.44%
2020-โ‚น221.90-21.84%
2019-โ‚น283.88-24.58%
2018-โ‚น376.41675.93%
2017-โ‚น48.51-68.05%
2016-โ‚น151.82168.25%
2015-โ‚น56.60-55%
2014-โ‚น125.773400%
2013-โ‚น3.59-108.68%
2012โ‚น41.4124.49%
2011โ‚น33.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น159.01 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.52-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น682.20-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น585.73-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,171-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,843-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น266.81-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA